Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.
about
Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung CancerProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerCan we unlock the potential of IGF-1R inhibition in cancer therapy?TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1.The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trialThe Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical AspectsVav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situThe hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.Role of IGF-1 receptor in radiation response.Type I insulin-like growth factor receptor signaling in hematological malignancies.Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistanceEpidermal growth factor receptor imaging in human head and neck cancer xenografts.Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors.IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination.Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.The impact of the IGF-1 system of cancer cells on radiation response - An in vitro study.
P2860
Q26740210-381437E8-B573-4286-BF1F-81938E84C7E1Q26852215-6F84B611-3EDC-4E78-8C02-B380F7B54BC3Q34336988-BFCAA7ED-0C52-41F2-B4CF-21730AE56C81Q34654685-412E1669-6889-47EA-8974-235CF5679507Q34984126-74095F33-9E43-45FF-9C29-2D9392939204Q35078950-8686F37B-4F55-42B3-ADCE-2F5F6A92CF81Q35184951-135BD3CB-A3DB-425C-8938-300BF35CD4A0Q35649008-8ECB46E7-AB6B-49C6-BA3A-D2C036F70BE0Q35762239-F4455D3A-817D-49A5-AAF6-0772C36A202CQ37702186-C43E923E-FCEF-4648-9B14-02C9E76C18C4Q38118934-D7A1C660-775A-4F33-A0D5-BCD39A64F345Q38561772-F96499AA-C23A-4E82-9416-719F15ACF24EQ38869420-B67E34A5-5E07-4914-B933-B5F8756A2D64Q38869428-917DA1B3-E940-4CFF-B662-B6BCCA08CE65Q38927010-AA07F74E-E5AF-4C3B-ACA1-E79ED3CD1E11Q38941146-80ACEF79-0476-4850-A4DF-CD4817CFDE67Q38943947-253B9828-4375-4C21-BEAA-55DE0C8E8E35Q41303851-DE433A83-B02B-44B3-92C3-0F1832D83791Q47707843-3D128EE8-D37F-4CB3-A621-4243408BC638Q52617485-E4C9C1BD-2F87-4A83-835A-9D0989AF7F54Q54118814-6EA0D802-74A3-4B94-BFDA-047959C21752
P2860
Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@ast
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@en
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@nl
type
label
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@ast
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@en
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@nl
prefLabel
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@ast
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@en
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@nl
P2093
P2860
P1476
Combination of anti-IGF-1R ant ...... per respiratory tract cancers.
@en
P2093
David Molkentine
David Valdecanas
K Kian Ang
Luka Milas
Mylin Torres
Nalini Patel
Oliver Riesterer
Qiuan Yang
P2860
P304
P356
10.1016/J.IJROBP.2010.10.003
P407
P577
2010-12-02T00:00:00Z